BE729914A - - Google Patents

Info

Publication number
BE729914A
BE729914A BE729914DA BE729914A BE 729914 A BE729914 A BE 729914A BE 729914D A BE729914D A BE 729914DA BE 729914 A BE729914 A BE 729914A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE729914A publication Critical patent/BE729914A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE729914D 1968-03-22 1969-03-14 BE729914A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR144905A FR314F (cg-RX-API-DMAC7.html) 1968-03-22 1968-03-22

Publications (1)

Publication Number Publication Date
BE729914A true BE729914A (cg-RX-API-DMAC7.html) 1969-09-15

Family

ID=8647868

Family Applications (1)

Application Number Title Priority Date Filing Date
BE729914D BE729914A (cg-RX-API-DMAC7.html) 1968-03-22 1969-03-14

Country Status (4)

Country Link
BE (1) BE729914A (cg-RX-API-DMAC7.html)
DE (1) DE1914456A1 (cg-RX-API-DMAC7.html)
FR (1) FR314F (cg-RX-API-DMAC7.html)
GB (1) GB1196229A (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2332921T1 (sl) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
EA016558B1 (ru) 2003-06-17 2012-05-30 Арена Фармасьютикалз, Инк. Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
EP2111859A1 (en) 2004-12-23 2009-10-28 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ, インコーポレイテッド 8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
WO2008070111A2 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
SG10201506870PA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Salts of lorcaserin with optically active acids
KR20180094131A (ko) 2010-09-01 2018-08-22 에자이 알앤드디 매니지먼트 가부시키가이샤 신장 손상을 갖는 개체에 대한 로카세린의 투여
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
SG188362A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
WO2014058441A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
DE1914456A1 (de) 1971-06-16
GB1196229A (en) 1970-06-24
FR314F (cg-RX-API-DMAC7.html) 1970-05-25

Similar Documents

Publication Publication Date Title
AU1946070A (cg-RX-API-DMAC7.html)
AU428130B2 (cg-RX-API-DMAC7.html)
AU2374870A (cg-RX-API-DMAC7.html)
FR314F (cg-RX-API-DMAC7.html)
AU429879B2 (cg-RX-API-DMAC7.html)
AU416157B2 (cg-RX-API-DMAC7.html)
AU2581067A (cg-RX-API-DMAC7.html)
AU421558B1 (cg-RX-API-DMAC7.html)
AU2580267A (cg-RX-API-DMAC7.html)
AR203075Q (cg-RX-API-DMAC7.html)
AU3224368A (cg-RX-API-DMAC7.html)
AU4744468A (cg-RX-API-DMAC7.html)
AU479894A (cg-RX-API-DMAC7.html)
BE709479A (cg-RX-API-DMAC7.html)
BE727220A (cg-RX-API-DMAC7.html)
BE727173A (cg-RX-API-DMAC7.html)
BE727643A (cg-RX-API-DMAC7.html)
BE709446A (cg-RX-API-DMAC7.html)
BE726983A (cg-RX-API-DMAC7.html)
BE726625A (cg-RX-API-DMAC7.html)
BE726245A (cg-RX-API-DMAC7.html)
AU4224469A (cg-RX-API-DMAC7.html)
AU4270368A (cg-RX-API-DMAC7.html)
BE727652A (cg-RX-API-DMAC7.html)
AU479393A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: LABORATOIRES HOUDE

Effective date: 19890314